In English | En español
Questions About Cancer? 1-800-4-CANCER

Find News Releases

Search For:
Between these dates:

Page Options

  • Print This Page
  • Email This Document
News from NCI
  • Investigators discover new gene that affects clearance of hepatitis C virus
    NCI Press Release

    (Posted: 01/07/2013) - Scientists have discovered a new human interferon gene, Interferon Lambda 4 (IFNL4), that affects clearance of the hepatitis C virus. They also identified an inherited genetic variant within IFNL4 that predicts how people respond to treatment for hepatitis C infection.

  • NIH study suggests gene variation may shape bladder cancer treatment
    NCI Press Release

    (Posted: 12/26/2012) - Patients who have inherited a specific common genetic variant develop bladder cancer tumors that strongly express a protein known as prostate stem cell antigen (PSCA), which is also expressed in many pancreatic and prostate tumors, according to research at the National Institutes of Health.

  • NCI Central Institutional Review Board Receives Accreditation
    NCI News Note

    (Posted: 12/12/2012) - The Association for the Accreditation of Human Research Protection Programs has awarded the NCI Central Institutional Review Board full accreditation. AAHRPP awards accreditation to organizations demonstrating the highest ethical standards in clinical research. Achieving accreditation establishes that the NCI CIRB has robust review processes in place to ensure the safety and protection of people who participate in NCI-funded clinical studies.

  • Provocative Questions in Cancer Research: National Cancer Institute Science Writers’ Seminar

    (Posted: 11/27/2012, Updated: 12/12/2012) - science writers' seminar to discuss various aspects of one of NCI’s signature efforts -- the Provocative Questions project. Discussion will focus on the scientific research that surrounds some of these questions.

  • This is an image of a genetic plot showing results from a GWAS study of never-smoking Asian women; the image is overlaid on a lung X-ray.
    Gene variations linked to lung cancer susceptibility in Asian women
    NCI Press Release

    (Posted: 11/13/2012) - An international group of scientists has identified three genes that predispose Asian women who have never smoked to lung cancer. The discovery of specific genetic variations, which have not previously been associated with lung cancer risk in other populations, provides further evidence that risk of lung cancer among never-smokers, especially Asian women, may be associated with certain unique genetic characteristics that distinguishes it from lung cancer in smokers.

  • Increased risk of chronic lymphocytic leukemia in Chernobyl cleanup workers
    NCI News Note

    (Posted: 11/08/2012) - A new study found a significantly elevated risk for chronic lymphocytic leukemia among workers who were engaged in recovery and clean-up activities following the Chernobyl power plant accident in 1986.

  • This bar graph displays the years of life gained when participants met various percentages of  HHS guidelines for physical activity. 50% = 1.8 years.  100% = 3.4 years. 200% = 4.2 years. 300% = 4.5 years.
    NIH study finds leisure-time physical activity extends life expectancy as much as 4.5 years
    NCI Press Release

    (Posted: 11/06/2012) - Leisure-time physical activity is associated with longer life expectancy, even at relatively low levels of activity and regardless of body weight, according to a study by a team of researchers led by the NCI. The study, which found that people who engaged in leisure-time physical activity had life expectancy gains of as much as 4.5 years, appeared Nov. 6, 2012, in PLoS Medicine.
    View the article in Spanish

  • NIH study uncovers new mechanism of action for class of chemotherapy drugs
    NCI Press Release

    (Posted: 11/01/2012) - NIH researchers have discovered a significant new mechanism of action for a class of chemotherapy drugs known as poly (ADP-ribose) polymerase inhibitors, or PARP inhibitors. They have also identified differences in the toxic capabilities of three drugs in this class which are currently being tested in clinical trials. Prior to this study, PARP inhibitors were thought to work primarily by blocking PARP enzyme activity, thus preventing the repair of DNA damage and ultimately causing cell death.

  • Gene variant linked to lung cancer risk
    NCI News Note

    (Posted: 10/09/2012) - A variation of the gene NFKB1, called rs4648127, is associated with an estimated 44 percent reduction in lung cancer risk. When this information, derived from samples obtained as part of a large NCI-sponsored prevention clinical trial, was compared with data on a different sample collection from NCI’s genome-wide association studies (GWAS), lung cancer risk was still estimated to be lower, but only by 21 percent.

  • HIV infection connected to rising anal cancer rates in men in the U.S.
    NCI News Note

    (Posted: 10/05/2012) - Human immunodeficiency virus (HIV) infection contributes substantially to the epidemic of anal cancer in men, but not women in the United States, according to new research from NCI. Chart shows overall incidence rates of anal cancers in general population with dashed line showing those with HIV infection.

< Previous  1 2 3 4 5 6 7 8 9 10  Next >